SELECTRA J. LAMARCK BIOTECH CLASS DSELECTRA J. LAMARCK BIOTECH CLASS DSELECTRA J. LAMARCK BIOTECH CLASS D

SELECTRA J. LAMARCK BIOTECH CLASS D

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪294.70 K‬EUR
Fund flows (1Y)
Dividend yield (indicated)
Discount/Premium to NAV
−4.5%
Shares outstanding
‪3.16 K‬
Expense ratio
3.36%

About SELECTRA J. LAMARCK BIOTECH CLASS D


Issuer
J Lamarck SpA
Brand
Selectra Investments
Inception date
Jan 24, 2011
Structure
Luxembourg SICAV
Index tracked
No Underlying Index
Management style
Active
Dividend treatment
Capitalizes
Primary advisor
J Lamarck SpA
ISIN
LU1246176264
The main objective of this Sub-Fund is to profit from increasing share prices in the biotechnology sector. The focus is on mature top tier pharmaceutical biotech companies and companies with interesting pipeline of products in development in a single or numerous markets, like Nasdaq or NYSE.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Active
Geography
Global
Weighting scheme
Proprietary
Selection criteria
Proprietary
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
76%23%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Broaden your horizons with more funds linked to SELJLB via country, focus, and more.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
SELJLB trades at 87.630 EUR today, its price has risen 5.62% in the past 24 hours. Track more dynamics on SELJLB price chart.
SELJLB net asset value is 90.40 today — it's risen 11.87% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
SELJLB assets under management is ‪294.70 K‬ EUR. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
SELJLB price has risen by 8.04% over the last month, and its yearly performance shows a −18.17% decrease. See more dynamics on SELJLB price chart.
NAV returns, another gauge of an ETF dynamics, showed a −13.80% decrease in three-month performance and has decreased by −16.60% in a year.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
SELJLB invests in stocks. See more details in our Analysis section.
SELJLB expense ratio is 3.36%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, SELJLB isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, SELJLB technical analysis shows the sell rating and its 1-week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating SELJLB shows the sell signal. See more of SELJLB technicals for a more comprehensive analysis.
No, SELJLB doesn't pay dividends to its holders.
SELJLB trades at a premium (4.46%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
SELJLB shares are issued by J Lamarck SpA
SELJLB follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Jan 24, 2011.
The fund's management style is active, aiming to outperform its benchmark index by actively selecting and adjusting assets. The goal is to achieve returns that exceed those of the index the fund tracks.